These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 29218503)
21. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
22. Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. McNaught KS; Belizaire R; Jenner P; Olanow CW; Isacson O Neurosci Lett; 2002 Jul; 326(3):155-8. PubMed ID: 12095645 [TBL] [Abstract][Full Text] [Related]
23. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
24. [Morphochemical changes in the substantia nigra cellular structures in Parkinson's disease]. Salkov VN; Khudoerkov RM; Voronkov DN; Sobolev VB; Kutukova KA Arkh Patol; 2017; 79(5):3-9. PubMed ID: 29027522 [TBL] [Abstract][Full Text] [Related]
25. Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in Parkinson's disease. Prasad H Gene; 2024 Nov; 927():148737. PubMed ID: 38945311 [TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)? Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716 [TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. Grünblatt E; Riederer P J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080 [TBL] [Abstract][Full Text] [Related]
28. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease. Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081 [TBL] [Abstract][Full Text] [Related]
29. Nuclear localization of the 20S proteasome subunit in Parkinson's disease. Nakamura A; Kitami T; Mori H; Mizuno Y; Hattori N Neurosci Lett; 2006 Oct; 406(1-2):43-8. PubMed ID: 16911859 [TBL] [Abstract][Full Text] [Related]
30. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
31. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211 [TBL] [Abstract][Full Text] [Related]
32. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760 [TBL] [Abstract][Full Text] [Related]
33. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease. Pappolla MA; Shank DL; Alzofon J; Dudley AW Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008 [TBL] [Abstract][Full Text] [Related]
34. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675 [TBL] [Abstract][Full Text] [Related]
35. Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. Gröger A; Kolb R; Schäfer R; Klose U PLoS One; 2014; 9(1):e84081. PubMed ID: 24416192 [TBL] [Abstract][Full Text] [Related]
36. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474 [TBL] [Abstract][Full Text] [Related]
37. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Goto S; Hirano A; Matsumoto S Ann Neurol; 1989 Dec; 26(6):766-70. PubMed ID: 2557795 [TBL] [Abstract][Full Text] [Related]
38. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship. Parent M; Parent A Can J Neurol Sci; 2010 May; 37(3):313-9. PubMed ID: 20481265 [TBL] [Abstract][Full Text] [Related]
39. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Tompkins MM; Basgall EJ; Zamrini E; Hill WD Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329 [TBL] [Abstract][Full Text] [Related]
40. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]